RE:RE:RE:RE:GREAT NEWS - bids are building up, eomLOL.
I think they have learned from SONA missteps, and now CBDT is down to $0.98 from a high a week ago fo $2. This is probably based on 4000 tests a day versus 33,000 saliva tests-for-at-home production from THRM. And that will probably scale to 2M-5M a month as revenue starts coming in.
I believe in some of the THRM deck, they cost per test was $30...that $30M per month...and all revenues are THRM's. So this thing is probably $5-10 per share by HC/FDA/CE announcement, and initial sales announcements...which I expect will happen back to back.
Remeber... 7 Billion people in the world and 11% o US is vacinated or 33M People. ANd US is one of the highest in vacination rates...higher than Canada...
So I'll wait for HC, FDA and CE to approve, as I think as the scientist have been prepping for the test, the sales team has been lining up the sales.
GLTA